引用本文:姜俊杰1 王建农2 谢雁鸣1.基于个体化治疗思想的中药群体药代动力学刍议[J].世界中医药,2014,9(09):. |
|
基于个体化治疗思想的中药群体药代动力学刍议 |
Chinese Medicine Group Pharmacokinetic based on Individualized Treatment |
投稿时间:2014-08-06 |
DOI:10.3969/j.issn.1673-7202.2014.09.002 |
中文关键词: 中药群体药代动力学 个体化治疗 关键问题 |
English Keywords:Chinese medicine group pharmacokinetics Individualized treatment Critical issues |
基金项目:中国中医科学院客座研究员联合创新项目(编号:ZZ070834);中国中医科学院科技创新团队建设项目(编号:PY1303);国家“重大新药创制”科技重大专项(编号:2009ZX09502-030) |
|
摘要点击次数: 1354 |
全文下载次数: 1828 |
中文摘要: |
目前,临床中,医生常不考虑患者的生理、病理等多种因素,而采用固定的治疗剂量对患者进行治疗,常造成疗效不佳、不良反应增多等情况。因此,开展可体现个体化治疗思想的群体药代动力学尤为重要。本文针对个体化治疗的必要性、中医理论中的个体化治疗及其局限性、开展中药群体药代动力学的意义、研究对象及关键问题进行详细阐述。 |
English Summary: |
Nowadays doctors do not often take into account physiological and pathological factors of patients, instead fixed drug dosage are applied to all patients, resulting in poor efficacy and adverse reactions. The author think individualized treatment using drug group pharmacokinetics is particularly important. The paper deals with the need for individualized treatment of traditional Chinese medicine, the limitations, significance of Chinese medicine group pharmacokinetics, and key issues in details. |
查看全文 查看/发表评论 下载PDF阅读器 |